COVID-19 and Esophageal Atresia Version 2

Question Title

* 1. email of reporting clinician

Question Title

* 2. Center

Question Title

* 3. Country

Question Title

* 4. How the patient had a confirmation of SARS-CoV-2 infection

PCR

Rapid test

Other (considered positive after contact with an infected person)

Question Title

* 5. Age

Question Title

* 6. Weight (kg)

Question Title

* 7. Height (cm)

Question Title

* 8. Type of atresia

Type A

Type B

Type C

Type D

Type E

Question Title

* 9. Gender

Male

Female

Question Title

* 10. Associated malformation

Cardiac

Other

None

Question Title

* 11. Associated respiratory problem

Tracheomalacia

Asthma

Recurrent chest infections

Aspirations

Aortopexia

On inhaled steroids

Question Title

* 12. Associated digestive problems

GERD

PPI treatment

Anastomotic stricture < or = 3 dilatations

Anastomotic stricture > 3 dilatations

Eosinophilic esophagitis

Swallowed steroids

Question Title

* 13. Symptoms at presentation

Cough

Fever > 38 degrees

Vomiting

Diarrhea

Rhinitis

Dyspnea

Other (please describe)

Question Title

* 14. List all medications prior to SARS-CoV-2 infection

Question Title

* 15. White blood cells count (peak during infection)

Question Title

* 16. CRP (mg/L) (peak during infection)

Question Title

* 17. Ped ICU admission needed

Yes

Question Title

* 18. Number of days in ICU

Question Title

* 19. Results of Chest X-ray/CT-Scan

Question Title

* 20. Respiratory support at peak of COVID-19

None

Oxygen

High flow nasal canula

BIPAP

CPAP

Conventional mechanical ventlation

ECMO

Question Title

* 21. Number of days since onset of illness (days) to reach the peak of COVID-19

Question Title

* 22. Specific therapy directed to SARS-CoV-2

Question Title

* 23. Other organs affected

Liver

Kidney

Brain

Cardiac

Question Title

* 24. Outcome

No hospitalization

Admitted on the ward and discharged

Need of ICU

Death